Quanta AI Inc.

Quanta AI Inc.

0.03
CAD
+0.00
(-14.29%)
-0.18EPS
Nov 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.09
0.34
0.46
1.46
4.55
2.36
0.64
0.34
0.11
0.11
Basic EPS, GAAP
-0.54
-0.22
-0.1
-0.09
-2.15
-2.92
-0.37
-0.59
0.84
-1.34
-1.02
-0.16
-0.18
-0.18
Free Cash Flow per Basic Share
-0.63
-0.14
-0.24
-0.1
-1.7
-0.84
-0.16
-0.07
1.06
-0.18
-0.59
-0.08
-0.05
-0.05
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.85
0.7
0.6
0.51
1.65
0.65
0.37
0.36
2.74
1.66
0.76
0.03
-0.01
-0.01
Tangible Book Value per Share
0.85
0.7
0.6
0.51
0.31
-0.34
-0.39
-0.23
1.18
0.66
-0.18
0.03
-0.01
-0.01
Basic Weighted Avg Shares
- -
- -
- -
- -
2
7
7
8
11
13
13
19
69
70
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
2
3
12
49
30
9
6
7
7
Operating Margin (%)
- -
- -
- -
- -
-1,538.95
-280.21
-94.56
-34.41
22.44
-7.87
-133.7
-35.38
-41.92
-41.92
Depreciation Expense
- -
- -
- -
- -
- -
3
1
1
2
3
3
1
1
1
Net Income, GAAP
- -
- -
- -
- -
-5
-19
-3
-5
9
-17
-14
-3
-13
-13
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
22.74
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-2,332.85
-869.81
-81.83
-40.44
18.54
-56.61
-159.28
-47.2
-169.23
-169.23
Working Capital
- -
- -
- -
- -
3
-3
-4
-2
14
6
-5
- -
-2
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
3
1
2
2
Total Equity
- -
- -
- -
- -
9
4
3
3
32
23
10
1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
41.59
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
49.81
- -
- -
- -
- -
- -
Return on Common Equity (%)
-40.31
-27.87
-15.41
-16.87
-115.42
-289.72
-76.51
-162.74
50.87
-62.47
-81.99
-55.75
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
153
153
Market Capitalization
- -
- -
- -

Working Capital

CAD

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
4
6
2
Cash, Cash Equivalents & STI
- -
2
1
Accounts Receivable, Net
2
3
1
Inventories
- -
- -
- -
Total Current Liabilities
5
3
4
Payables & Accruals
3
3
3
ST Debt
2
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
491.51%
91.89%
-263.15%
Free Cash Flow
907.06%
-363.86%
105.85%
Net Income, GAAP
1,466.05%
-71.44%
313.03%
Sales/Revenue/Turnover
- -
35.52%
15.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
2
2
- -
6
2026
1
1
3
2
7

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.08
-0.02
0.09
-0.15
-0.16
2026
-0.03
-0.02
-0.02
-0.06
-0.18

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Michael Kron
Full Time Employees
21
Sector
Health technology
Industry
Medical specialties
Address
90 Eglinton Ave E Toronto ON Canada M4P 2Y3
IPO Date
Jun 12, 2017
Business
Quanta AI, Inc. is a data technology and artificial intelligence company, which engages in the collection and sale of data from retail point of sale terminals. The firm provides artificial intelligence for government and corporations, which can access the business-critical data in real-time without disrupting the transaction processing through dataTap and dashboard systems. Its products include cyber security, health security, and telemedicine. The company was founded by Andrew Ryu on March 4, 2011 and is headquartered in Toronto, Canada.

Company News

  • QNTA Secures Additional Enterprise Software Automation Contracts

  • Quanta AI Completes Name Change

  • Datametrex Announces Director Resignation and Appointment of Director

  • Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing

  • Datametrex Announces Name Change and Management Changes

  • Datametrex Announces Annual and Special Meeting Voting Results

  • Datametrex Announces Transition to Semi-Annual Financial Reporting

  • Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative

  • Datametrex Announces Rebranding of Paymetrex to QuantIP Licensing Corp.

  • Datametrex Announces Enterprise Software Automation Contracts

  • Datametrex Secures New Nutanix Infrastructure Contracts as Enterprise Data Centre Modernization Accelerates

  • Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review

  • Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership

  • Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

  • Datametrex Enters Strategic Agreement with Hilco Global to Advance Patent Monetization

  • Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market

  • Datametrex Integrates AI to Healthcare To Enhance Efficiencies

  • Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program

  • Datametrex Receives $1M Order from Fortune 500 Client

  • Datametrex Received $500,000 Purchase Order For Data Centre Solutions